Related Experiment Video

Updated: Apr 26, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

11.1K

Alternative therapy for medically refractory angina: enhanced external counterpulsation and transmyocardial laser

Ozlem Soran1

  • 1Heart and Vascular Institute, University of Pittsburgh, 200 Lothrop Street, Scaife Hall S-623, Pittsburgh, PA 15213, USA.

Cardiology Clinics
|August 6, 2014
PubMed

Insights

Medically refractory angina pectoris (RAP) remains challenging despite conventional treatments. External enhanced counterpulsation therapy shows promise as a complementary first-line approach for managing this condition.

Area of Science:

  • Cardiology
  • Vascular Medicine

Background:

  • Medically refractory angina pectoris (RAP) signifies severe angina unresponsive to standard treatments, including revascularization.
  • Current treatments for coronary artery disease (CAD) manage symptoms but do not halt disease progression.
  • There is a need for novel therapeutic strategies to prevent CAD progression and symptom recurrence.

Purpose of the Study:

  • To evaluate external enhanced counterpulsation (EECP) as a treatment for medically refractory angina pectoris (RAP).
  • To explore EECP's role in managing coronary artery disease (CAD) and complementing revascularization.

Main Methods:

  • Review of existing data and clinical evidence supporting EECP in CAD management.
  • Analysis of EECP's efficacy in patients with refractory angina pectoris.

Main Results:

  • External enhanced counterpulsation therapy is a viable treatment option for CAD.
  • EECP can effectively complement invasive revascularization procedures.

Conclusions:

  • External enhanced counterpulsation therapy should be considered a first-line treatment for medically refractory angina pectoris.
  • EECP offers a promising therapeutic modality for managing complex CAD and improving patient outcomes.

Keywords:
Coronary artery diseaseEnhanced external counterpulsation therapyMedically refractory anginaTransmyocardial laser revascularization

More Related Videos

Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.5K
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

4.2K

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
485
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
652
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
342